Zai Lab (ZLAB) News Today $35.40 -0.27 (-0.76%) Closing price 04:00 PM EasternExtended Trading$35.20 -0.20 (-0.56%) As of 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Zai Lab (NASDAQ:ZLAB) Shares Gap Down - Time to Sell?Zai Lab (NASDAQ:ZLAB) Shares Gap Down - What's Next?March 22 at 12:11 PM | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Shares Purchased by DCF Advisers LLCDCF Advisers LLC increased its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 53.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,750 shares of the company's stock after buying an additionalMarch 22 at 6:05 AM | marketbeat.comZai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) GrowthMarch 21, 2025 | seekingalpha.comZai Lab Limited (NASDAQ:ZLAB) Insider Rafael Amado Sells 3,000 SharesZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Rafael Amado sold 3,000 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $38.41, for a total value of $115,230.00. Following the completion of the sale, the insider now directly owns 30,834 shares of the company's stock, valued at approximately $1,184,333.94. This represents a 8.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 20, 2025 | marketbeat.comZai Lab: Still Attractive Despite Higher Costs And Added Trade War RisksMarch 20, 2025 | seekingalpha.comRafael Amado Sells 3,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockMarch 20, 2025 | insidertrades.comPrivium Fund Management B.V. Has $4.85 Million Position in Zai Lab Limited (NASDAQ:ZLAB)Privium Fund Management B.V. decreased its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 14.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 185,062 shares of the company's stockMarch 20, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Invests $1.67 Million in Zai Lab Limited (NASDAQ:ZLAB)Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 63,909 shares of the company's stock, valued at approximatelMarch 18, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Given New $51.00 Price Target at JPMorgan Chase & Co.March 16, 2025 | americanbankingnews.comZai Lab (NASDAQ:ZLAB) Sets New 52-Week High Following Analyst UpgradeMarch 16, 2025 | americanbankingnews.comZai Lab (NASDAQ:ZLAB) Sets New 1-Year High After Analyst UpgradeZai Lab (NASDAQ:ZLAB) Reaches New 52-Week High Following Analyst UpgradeMarch 15, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Price Target Raised to $51.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. boosted their price objective on shares of Zai Lab from $44.00 to $51.00 and gave the company an "overweight" rating in a research report on Thursday.March 14, 2025 | marketbeat.comIs Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?March 14, 2025 | insidermonkey.comConnor Clark & Lunn Investment Management Ltd. Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB)Connor Clark & Lunn Investment Management Ltd. increased its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 39.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 841,735 shares of the company's stock after purchasing an additional 237,582 shares duriMarch 14, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)March 13, 2025 | markets.businessinsider.comZai Lab price target raised to $51 from $44 at JPMorganMarch 13, 2025 | markets.businessinsider.comZai Lab Limited Announces Equity Incentive GrantsMarch 13, 2025 | tipranks.comZai Lab announces acceptance of BLA for TIVDAK in cervical cancerMarch 12, 2025 | markets.businessinsider.comZai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical CancerMarch 12, 2025 | businesswire.comZai Lab (ZLAB) Initiated with a Buy at ScotiabankMarch 10, 2025 | markets.businessinsider.comScotiabank Initiates Coverage of Zai Lab Limited - Depositary Receipt () (ZLAB) with Sector Outperform RecommendationMarch 8, 2025 | msn.comZai Lab (NASDAQ:ZLAB) Reaches New 1-Year High - Time to Buy?Zai Lab (NASDAQ:ZLAB) Hits New 12-Month High - Here's What HappenedMarch 8, 2025 | marketbeat.comScotiabank Begins Coverage on Zai Lab (NASDAQ:ZLAB)Scotiabank began coverage on Zai Lab in a research report on Friday. They issued a "sector outperform" rating and a $55.00 price objective for the company.March 8, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Position Decreased by Candriam S.C.A.Candriam S.C.A. decreased its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 375,479 shares of the company's stock after sMarch 8, 2025 | marketbeat.comZai Lab initiated with an Outperform at ScotiabankMarch 7, 2025 | markets.businessinsider.comCantor Fitzgerald Weighs in on Zai Lab FY2025 EarningsZai Lab Limited (NASDAQ:ZLAB - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Zai Lab in a note issued to investors on Tuesday, March 4th. Cantor Fitzgerald analyst L. Watsek expects that the company will post earnings per share of ($1March 7, 2025 | marketbeat.comCantor Fitzgerald Upgrades Zai Lab (NASDAQ:ZLAB) to "Strong-Buy"Cantor Fitzgerald upgraded Zai Lab to a "strong-buy" rating in a report on Tuesday.March 6, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Insider Sells $479,661.12 in StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 14,544 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $32.98, for a total transaction of $479,661.12. Following the completion of the sale, the insider now owns 14,328 shares of the company's stock, valued at $472,537.44. This trade represents a 50.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.March 5, 2025 | marketbeat.comYing Du Sells 50,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 50,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $32.44, for a total value of $1,622,000.00. Following the completion of the sale, the chief executive officer now owns 494,117 shares in the company, valued at approximately $16,029,155.48. This represents a 9.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.March 5, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CEO Sells $1,723,500.00 in StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 50,000 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $34.47, for a total value of $1,723,500.00. Following the completion of the sale, the chief executive officer now directly owns 494,117 shares in the company, valued at approximately $17,032,212.99. The trade was a 9.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.March 5, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Trading 3.8% Higher - Here's What HappenedZai Lab (NASDAQ:ZLAB) Shares Up 3.8% - Still a Buy?March 5, 2025 | marketbeat.comFrazor Titus Edmondson III Sells 14,544 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockMarch 5, 2025 | insidertrades.comB of A Securities Downgrades Zai Lab Limited - Depositary Receipt () (ZLAB)March 4, 2025 | msn.comZai Lab downgraded to Neutral from Buy at BofAMarch 3, 2025 | markets.businessinsider.comZai Lab (NASDAQ:ZLAB) Earns Neutral Rating from Bank of AmericaBank of America reissued a "neutral" rating and set a $36.10 price objective (up from $29.00) on shares of Zai Lab in a research report on Monday.March 3, 2025 | marketbeat.comZai Lab Announces Participation in Investor Conferences in March 2025March 3, 2025 | businesswire.comBrokers Offer Predictions for Zai Lab FY2026 EarningsZai Lab Limited (NASDAQ:ZLAB - Free Report) - Leerink Partnrs issued their FY2026 earnings per share estimates for Zai Lab in a report released on Thursday, February 27th. Leerink Partnrs analyst J. Chang forecasts that the company will post earnings per share of $0.18 for the year. The consensusMarch 3, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Just Released Its Annual Results And Analysts Are Updating Their EstimatesMarch 2, 2025 | finance.yahoo.comZai Lab added to APAC Conviction List at Goldman SachsMarch 2, 2025 | markets.businessinsider.comZai Lab (NASDAQ:ZLAB) Posts Earnings Results, Misses Expectations By $0.15 EPSZai Lab (NASDAQ:ZLAB - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.80) EPS for the quarter, missing the consensus estimate of ($0.65) by ($0.15). Zai Lab had a negative net margin of 76.14% and a negative return on equity of 36.97%.February 28, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Announces Earnings Results, Misses Expectations By $0.15 EPSZai Lab (NASDAQ:ZLAB - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.65) by ($0.15). Zai Lab had a negative return on equity of 36.97% and a negative net margin of 76.14%.February 28, 2025 | marketbeat.comZai Lab Ltd (ZLAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Path to ProfitabilityFebruary 28, 2025 | finance.yahoo.comZai Lab Limited (ZLAB) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comZai Lab Limited 2024 Q4 - Results - Earnings Call PresentationFebruary 27, 2025 | seekingalpha.comChina Biotech's Sales Jump 66% But Bottom Line Misses ViewsFebruary 27, 2025 | investors.comZai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate UpdatesFebruary 27, 2025 | businesswire.comIs Zai Lab Limited (ZLAB) the Best Performing Mid Cap Stock to Buy According to Analysts?February 26, 2025 | msn.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's WhyZai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's What HappenedFebruary 25, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Sees Unusually-High Trading Volume - Should You Buy?Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume - Still a Buy?February 24, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Shares Bought by Allianz Asset Management GmbHAllianz Asset Management GmbH grew its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 188.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,505,866 shares of the company's stock after purchasingFebruary 24, 2025 | marketbeat.com Remove Ads Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address ZLAB Media Mentions By Week ZLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼1.210.68▲Average Medical News Sentiment ZLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼95▲ZLAB Articles Average Week Remove Ads Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Summit Therapeutics News Intra-Cellular Therapies News Moderna News Genmab A/S News Dr. Reddy's Laboratories News Viatris News Ascendis Pharma A/S News Vaxcyte News Qiagen News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZLAB Stock Free ZLAB Stock Alerts